Evidence map›Paper›PMID 37945970›Full record

ArticleCancer gene therapy2024

Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8

Willemijn van der Wulp, Dennis F G Remst, Michel G D Kester, Renate S Hagedoorn, Paul W H I Parren, Sander I van Kasteren, Janine Schuurman, Rob C Hoeben, Maaike E Ressing, Boris Bleijlevens and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer gene therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. CD19-ReTARGCancers · 2025
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Willemijn van der WulpDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands. w.van_der_wulp@lumc.nl.ORCID 0000-0002-0364-1300
Dennis F G RemstDepartment of Hematology, Leiden University Medical Center, Leiden, the Netherlands.
Michel G D KesterDepartment of Hematology, Leiden University Medical Center, Leiden, the Netherlands.
Renate S HagedoornDepartment of Hematology, Leiden University Medical Center, Leiden, the Netherlands.
Paul W H I ParrenDepartment of Immunology, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0002-4365-3859
Sander I van KasterenDivision of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
Janine SchuurmanGenmab, Utrecht, the Netherlands.ORCID 0000-0002-9738-9926
Rob C HoebenDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0001-9443-8377
Maaike E RessingDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
Boris BleijlevensGenmab, Utrecht, the Netherlands.
Mirjam H M HeemskerkDepartment of Hematology, Leiden University Medical Center, Leiden, the Netherlands. m.h.m.heemskerk@lumc.nl.ORCID 0000-0001-6320-9133
Leiden University Medical Center · NLGenmab (Netherlands) · NLLeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody-mediated delivery of immunogenic epitopes to redirect virus-specific CD8

Indexed as

ImmunoconjugatesNeoplasmsCD8-Positive T-LymphocytesEpitopesEpitopes, T-LymphocyteHerpesvirus 4, HumanHumansEpitopesEpitopes, T-LymphocyteImmunoconjugates

Identifiers

PMID37945970
PMCPMC10794138
OpenAlexW4388532104

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.